MedTrace Logo

Autologous Mesenchymal Stem Cells Transplantation in Cervical Chronic and Complete Spinal Cord Injury

NCT02574572 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-11-28

No results posted yet for this study

Summary

The purpose of this study is to analyze the safety and efficacy of autologous bone marrow mesenchymal stem cell transplantation in patients with cervical chronic and complete spinal cord injury.

Conditions

  • Spinal Cord Injury

Interventions

BIOLOGICAL

Autologous mesenchymal cells transplantation

All patients will undergo laminectomy and autologous mesenchymal cells injection into the lesion area.

Sponsors & Collaborators

  • Hospital Sao Rafael

    lead OTHER

Principal Investigators

  • Ricardo Ribeiro-dos-Santos, PhD · Hospital São Rafael

  • Milena BP Soares, PhD · Hospital São Rafael

  • Bruno SF de Souza, MD, Msc · Hospital São Rafael

  • Ticiana F Larocca, MD, Msc · Hospital São Rafael

  • Rodrigo L Alves, MD, PhD · Hospital São Rafael

  • Carolina T Macedo, MD, MSc · Hospital São Rafael

  • André C Matos, MD · Hospital São Rafael

  • Cristiane F Villarreal, PhD · Fundação Oswaldo Cruz

  • Antônio Olímpio S Moura, MD · Hospital São Rafael

  • Eduardo Brazão, MD · Hospital São Rafael

  • Kátia N Silva, MSc · Hospital São Rafael

  • Daniela N Silva, MSc · Hospital São Rafael

  • Clarissa LM de Souza, MD · Hospital São Rafael

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-06
Primary Completion
2019-12-31
Completion
2020-06-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02574572 on ClinicalTrials.gov